Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
Sales of a groundbreaking new Alzheimer’s disease treatment from Eisai and Biogen are finally accelerating, after a sluggish launch last year. Biogen said Wednesday that the number of patie